1. Home
  2. OCS vs WLFC Comparison

OCS vs WLFC Comparison

Compare OCS & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • WLFC
  • Stock Information
  • Founded
  • OCS 2003
  • WLFC 1985
  • Country
  • OCS Switzerland
  • WLFC United States
  • Employees
  • OCS N/A
  • WLFC N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • WLFC Industrial Specialties
  • Sector
  • OCS Health Care
  • WLFC Consumer Discretionary
  • Exchange
  • OCS Nasdaq
  • WLFC Nasdaq
  • Market Cap
  • OCS 1.0B
  • WLFC 1.0B
  • IPO Year
  • OCS N/A
  • WLFC 1996
  • Fundamental
  • Price
  • OCS $19.18
  • WLFC $120.51
  • Analyst Decision
  • OCS Strong Buy
  • WLFC
  • Analyst Count
  • OCS 4
  • WLFC 0
  • Target Price
  • OCS $41.00
  • WLFC N/A
  • AVG Volume (30 Days)
  • OCS 99.7K
  • WLFC 56.5K
  • Earning Date
  • OCS 11-06-2025
  • WLFC 11-04-2025
  • Dividend Yield
  • OCS N/A
  • WLFC 1.32%
  • EPS Growth
  • OCS N/A
  • WLFC 17.99
  • EPS
  • OCS N/A
  • WLFC 16.70
  • Revenue
  • OCS $960,668.00
  • WLFC $674,381,000.00
  • Revenue This Year
  • OCS $32.89
  • WLFC $16.17
  • Revenue Next Year
  • OCS $1,043.16
  • WLFC $4.88
  • P/E Ratio
  • OCS N/A
  • WLFC $7.23
  • Revenue Growth
  • OCS N/A
  • WLFC 29.58
  • 52 Week Low
  • OCS $14.00
  • WLFC $115.21
  • 52 Week High
  • OCS $23.08
  • WLFC $235.43
  • Technical
  • Relative Strength Index (RSI)
  • OCS 43.14
  • WLFC 33.49
  • Support Level
  • OCS $19.00
  • WLFC $115.21
  • Resistance Level
  • OCS $19.63
  • WLFC $123.89
  • Average True Range (ATR)
  • OCS 0.74
  • WLFC 4.81
  • MACD
  • OCS -0.35
  • WLFC -0.51
  • Stochastic Oscillator
  • OCS 6.04
  • WLFC 28.49

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

Share on Social Networks: